Vimarsana
Biggest News Aggregation in the World

Page 2 - First Product News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from First Product. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In First Product Today - Breaking & Trending Today

SheMatters Raises $1.5M Seed Funding Round To Address Black Maternal Morbidity - Vimarsana News

SheMatters Raises $1.5M Seed Funding Round To Address Black Maternal Morbidity

The online platform aims to tackle Black medical neglect, and save the lives of Black mothers and their children.

Ciig Capital Partners II, Inc.: Zapp, a High Performance Two-Wheel Electric Vehicle Company, to Become Publicly Traded via Business Combination with CIIG Capital Partners II - Vimarsana News

Ciig Capital Partners II, Inc.: Zapp, a High Performance Two-Wheel Electric Vehicle Company, to Become Publicly Traded via Business Combination with CIIG Capital Partners II

Zapp's First Product, the i300 Performance City Bike, with its Carbon Composite Body, Delivers Premium Performance Capabilities to Urban Mobility RidersUnique Charging Solution with Ultra-Lightweight (6kg)

Remento Raises $3M Seed Round, Led by Upfront Ventures - Vimarsana News

Remento Raises $3M Seed Round, Led by Upfront Ventures

/PRNewswire/ -- Remento, a company dedicated to capturing and preserving family stories, today announced a $3 million seed round and the launch of its first...

Everest Medicines Announces Approval of Trodelvy in China for Second-Line Metastatic Triple-Negative Breast Cancer - Vimarsana News

Everest Medicines Announces Approval of Trodelvy in China for Second-Line Metastatic Triple-Negative Breast Cancer

- Trodelvy is Everest's First Product to Receive Regulatory Approval in China - - Everest Plans to Launch Commercial Sales of Trodelvy in China in Q4 2022 - - Conference call will be held to discuss the approval- SHANGHAI, June 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced today that China's National Medical Products Administration (NMPA) has approved ...

Everest Medicines Announces Approval of Trodelvy® in China for Second-Line Metastatic Triple-Negative Breast Cancer - Vimarsana News

Everest Medicines Announces Approval of Trodelvy® in China for Second-Line Metastatic Triple-Negative Breast Cancer

/PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing...